Terms: = Bone cancer AND TSC2, FLJ43106, 7249, ENSG00000103197, LAM, tuberin, TSC4
39 results:
1. Osteosarcoma's genetic landscape painted by genes' mutations.
Urban W; Krzystańska D; Piekarz M; Nazar J; Jankowska A
Acta Biochim Pol; 2023 Sep; 70(3):671-678. PubMed ID: 37717265
[TBL] [Abstract] [Full Text] [Related]
2.
Cho CY; Kang SH; Kim BC; Kim TK; Kim JH; Kim M; Sohn Y; Jung HS
Mol Med Rep; 2023 Oct; 28(4):. PubMed ID: 37594079
[TBL] [Abstract] [Full Text] [Related]
3. Prevalence and clinical implications of germline pathogenic variants in cancer predisposing genes in young patients across sarcoma subtypes.
Carvalho NA; Santiago KM; Maia JML; Costa FD; Formiga MN; Soares DCQ; Paixão D; Mello CAL; Costa CMLD; Rocha JCCD; Rivera B; Carraro DM; Torrezan GT
J Med Genet; 2023 Dec; 61(1):61-68. PubMed ID: 37536918
[TBL] [Abstract] [Full Text] [Related]
4. Clinical and Laboratory Characteristics of IgM Primary Plasma Cell Leukemia.
Wu Y; Zhang X; Ma X; Suo X; Li R
Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436385
[TBL] [Abstract] [Full Text] [Related]
5. Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas.
Gao X; Kady N; Wang C; Abdelrahman S; Gann P; Sverdlov M; Wolfe A; Brown N; Reneau J; Robida AM; Murga-Zamalloa C; Wilcox RA
Cancer Res Commun; 2022 Dec; 2(12):1727-1737. PubMed ID: 36970721
[TBL] [Abstract] [Full Text] [Related]
6. Knockdown of let-7b in leukemia associated macrophages inhibit acute myeloid leukemia progression.
Tian C; Li Y; Si J; Kang J; Chen Z; Nuermaimaiti R; Wang Y; Yu Y; Zhao Z; Wang X; Zhang Y; Zhao H; Yang H; You MJ; Zheng G; Wang L
Hematol Oncol; 2023 Aug; 41(3):510-519. PubMed ID: 36579468
[TBL] [Abstract] [Full Text] [Related]
7. LncRNA PVT-1 promotes osteosarcoma cancer stem-like properties through direct interaction with TRIM28 and tsc2 ubiquitination.
Tsang SV; Rainusso N; Liu M; Nomura M; Patel TD; Nakahata K; Kim HR; Huang S; Rajapakshe K; Coarfa C; Man TK; Rao PH; Yustein JT
Oncogene; 2022 Dec; 41(50):5373-5384. PubMed ID: 36348010
[TBL] [Abstract] [Full Text] [Related]
8. Primary Cutaneous Malignant Perivascular Epithelioid Cell Tumor Mimicking Undifferentiated Pleomorphic Sarcoma: A Report of a Rare Entity.
Neumann NM; Cornelia Ding CK; Borgen A; Corvera CU; North JP; Qorbani A; Horvai AE
Am J Dermatopathol; 2022 Oct; 44(10):768-773. PubMed ID: 36122336
[TBL] [Abstract] [Full Text] [Related]
9. Phase II Study of TQB2450, a Novel PD-L1 Antibody, in Combination with Anlotinib in Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma.
Liu J; Gao T; Tan Z; Li S; Xu J; Bai C; Xue R; Xie L; Zhang L; Fan Z; Guo W
Clin Cancer Res; 2022 Aug; 28(16):3473-3479. PubMed ID: 35675031
[TBL] [Abstract] [Full Text] [Related]
10. Effectiveness of prophylactic antiviral therapy in reducing HBV reactivation for HBsAg-positive recipients following allogeneic hematopoietic stem cell transplantation: a multi-institutional experience from an HBV endemic area.
Wu Y; Chen Y; Zhu P; Ye B; Lu Y; Shi J; Tan Y; Zhao Y; Yu J; Lai X; Lan J; Si T; Ni L; Huang H; Luo Y
Ann Hematol; 2022 Mar; 101(3):631-641. PubMed ID: 34981143
[TBL] [Abstract] [Full Text] [Related]
11. Tuberous sclerosis complex misdiagnosed as multiple metastases in a cervical cancer patient: case report and literature review.
Ye T; Feng L; Peng M; Yuan S; Chen Y; Liu X; Chen J
Ann Palliat Med; 2021 Oct; 10(10):11232-11238. PubMed ID: 34763482
[TBL] [Abstract] [Full Text] [Related]
12. Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations.
Northrup H; Aronow ME; Bebin EM; Bissler J; Darling TN; de Vries PJ; Frost MD; Fuchs Z; Gosnell ES; Gupta N; Jansen AC; Jóźwiak S; Kingswood JC; Knilans TK; McCormack FX; Pounders A; Roberds SL; Rodriguez-Buritica DF; Roth J; Sampson JR; Sparagana S; Thiele EA; Weiner HL; Wheless JW; Towbin AJ; Krueger DA;
Pediatr Neurol; 2021 Oct; 123():50-66. PubMed ID: 34399110
[TBL] [Abstract] [Full Text] [Related]
13. Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA).
Sauter M; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; d'Augères GB; de Vries PJ; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen A; Kingswood JC;
Orphanet J Rare Dis; 2021 Jul; 16(1):301. PubMed ID: 34229737
[TBL] [Abstract] [Full Text] [Related]
14. A Bama miniature pig model of monoallelic TSC1 mutation for human tuberous sclerosis complex.
Li X; Hu T; Liu J; Fang B; Geng X; Xiong Q; Zhang L; Jin Y; Liu X; Li L; Wang Y; Li R; Bai X; Yang H; Dai Y
J Genet Genomics; 2020 Dec; 47(12):735-742. PubMed ID: 33612456
[TBL] [Abstract] [Full Text] [Related]
15. Lymphangioleiomyomatosis Association with Underlying Genotype in Patients with Tuberous Sclerosis Complex.
Tian X; Glass JE; Kwiatkowski DJ; Towbin AJ; Li Y; Sund KL; Krueger DA; Franz DN; McCormack FX; Gupta N
Ann Am Thorac Soc; 2021 May; 18(5):815-819. PubMed ID: 33171065
[No Abstract] [Full Text] [Related]
16. lam-003, a new drug for treatment of tyrosine kinase inhibitor-resistant FLT3-ITD-positive AML.
Beeharry N; Landrette S; Gayle S; Hernandez M; Grotzke JE; Young PR; Beckett P; Zhang X; Carter BZ; Andreeff M; Halene S; Xu T; Rothberg J; Lichenstein H
Blood Adv; 2019 Nov; 3(22):3661-3673. PubMed ID: 31751472
[TBL] [Abstract] [Full Text] [Related]
17. Tibial perivascular epithelioid cell tumour (PEComa). A case report and literature review.
Técualt-Gómez R; Atencio-Chan A; Amaya-Zepeda RA; Cario-Méndez AG; González-Valladares R; Rodríguez-Franco JH
Rev Esp Cir Ortop Traumatol (Engl Ed); 2019; 63(3):239-245. PubMed ID: 30905544
[TBL] [Abstract] [Full Text] [Related]
18.
Kaur V; Kumar M; Kumar A; Kaur S
Drug Chem Toxicol; 2020 Jul; 43(4):398-408. PubMed ID: 30293450
[No Abstract] [Full Text] [Related]
19. Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab.
Zappulo E; Nicolini LA; Di Grazia C; Dominietto A; Lamparelli T; Gualandi F; Caligiuri P; Bruzzone B; Angelucci E; Viscoli C; Mikulska M
Infection; 2019 Feb; 47(1):59-65. PubMed ID: 30232604
[TBL] [Abstract] [Full Text] [Related]
20. Advanced sporadic renal epithelioid angiomyolipoma: case report of an extraordinary response to sirolimus linked to tsc2 mutation.
Espinosa M; Roldán-Romero JM; Duran I; de Álava E; Apellaniz-Ruiz M; Cascón A; Garrigos C; Robledo M; Rodriguez-Antona C
BMC Cancer; 2018 May; 18(1):561. PubMed ID: 29764404
[TBL] [Abstract] [Full Text] [Related]
[Next]